These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37109347)

  • 21. Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Fernández T; Viñuela M; Vidal C; Barrera F
    PLoS One; 2022; 17(2):e0263931. PubMed ID: 35176096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparisons of different exercise interventions on glycemic control and insulin resistance in prediabetes: a network meta-analysis.
    Huang L; Fang Y; Tang L
    BMC Endocr Disord; 2021 Sep; 21(1):181. PubMed ID: 34488728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Yu X; Wang Y; Lai J; Song T; Duan J
    Ir J Med Sci; 2023 Feb; 192(1):131-142. PubMed ID: 35366201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials.
    Cho K; Park S; Koyanagi A; Jacob L; Yon DK; Lee SW; Kim MS; Kim SU; Kim BK; Shin JI; Smith L
    Obes Rev; 2022 Sep; 23(9):e13464. PubMed ID: 35582982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions for promoting habitual exercise in people living with and beyond cancer.
    Bourke L; Homer KE; Thaha MA; Steed L; Rosario DJ; Robb KA; Saxton JM; Taylor SJ
    Cochrane Database Syst Rev; 2013 Sep; (9):CD010192. PubMed ID: 24065550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.
    Xiong Y; Peng Q; Cao C; Xu Z; Zhang B
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33801028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise interventions for cerebral palsy.
    Ryan JM; Cassidy EE; Noorduyn SG; O'Connell NE
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011660. PubMed ID: 28602046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver.
    Al-Jiffri O; Al-Sharif FM; Abd El-Kader SM; Ashmawy EM
    Afr Health Sci; 2013 Sep; 13(3):667-72. PubMed ID: 24250305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD.
    Oh S; Tsujimoto T; Kim B; Uchida F; Suzuki H; Iizumi S; Isobe T; Sakae T; Tanaka K; Shoda J
    JHEP Rep; 2021 Jun; 3(3):100253. PubMed ID: 33898958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.
    Haigh L; Kirk C; El Gendy K; Gallacher J; Errington L; Mathers JC; Anstee QM
    Clin Nutr; 2022 Sep; 41(9):1913-1931. PubMed ID: 35947894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of exercise training on inflammatory and cardiometabolic health markers in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials.
    Hejazi K; Wong A
    J Sports Med Phys Fitness; 2023 Feb; 63(2):345-359. PubMed ID: 35816146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of aerobic and resistance exercises in improving visceral adipose in patients with non-alcoholic fatty liver: a meta-analysis of randomized controlled trials.
    Fu L; Zhang W; Ao Y; Zheng Z; Hu H
    Z Gastroenterol; 2022 Nov; 60(11):1644-1658. PubMed ID: 35636454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats.
    Nikroo H; Hosseini SRA; Fathi M; Sardar MA; Khazaei M
    Physiol Behav; 2020 Dec; 227():113149. PubMed ID: 32888948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.
    Buzzetti E; Linden A; Best LM; Madden AM; Roberts D; Chase TJG; Freeman SC; Cooper NJ; Sutton AJ; Fritche D; Milne EJ; Wright K; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013156. PubMed ID: 34114650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of various interventions on non-alcoholic fatty liver disease (NAFLD): A systematic review and network meta-analysis.
    Wang X; Jin X; Li H; Zhang X; Chen X; Lu K; Chu C
    Front Pharmacol; 2023; 14():1180016. PubMed ID: 37063273
    [No Abstract]   [Full Text] [Related]  

  • 36. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance exercise training for fibromyalgia.
    Busch AJ; Webber SC; Richards RS; Bidonde J; Schachter CL; Schafer LA; Danyliw A; Sawant A; Dal Bello-Haas V; Rader T; Overend TJ
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD010884. PubMed ID: 24362925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 39. Exercise interventions on health-related quality of life for cancer survivors.
    Mishra SI; Scherer RW; Geigle PM; Berlanstein DR; Topaloglu O; Gotay CC; Snyder C
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007566. PubMed ID: 22895961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
    Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
    J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.